Overall, dapoxetine 30 mg or 60 mg is clearly associated with greater perceived overall improvement in PE compared with placebo. Country-specific health economics studies are needed to answer the following questions: Is on-demand use of dapoxetine more cost-effective than long-term once-daily use of other SSRIs for treatment of PE? In the paper by McMahon et al, the proportions achieving the composite patient-reported outcome were Of all patients, 9. Statistical Analyses We undertook a prospective cohort study. Furthermore, one of these studies also found significant differences between dapoxetine both 30 mg and 60 mg and placebo at all time points between baseline and end-of-study. These improvements were noted not only at the end-of-study but at all time points in between. · Priligy FDA Approval Status. FDA Approved: No. Brand name: Priligy. Generic name: dapoxetine. Company: ALZA Corporation. Treatment for: Premature . Dapoxetine [LY ], a selective serotonin reuptake inhibitor (SSRI), is structurally related to fluoxetine with antidepressant activity. Dapoxetine is the D-enantiomer of LY . This paper reviews the current evidence for use of dapoxetine in the treatment of PE in adult men. There is substantial evidence that dapoxetine 30 mg or 60 .